Clinical Trial Update: ZILRETTA in Subjects With Shoulder Osteoarthritis [Phase 3]

View source ↗

Summary

This update notes a Phase 3 clinical trial evaluating ZILRETTA for Glenohumeral osteoarthritis (shoulder osteoarthritis) and indicates the study is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glenohumeral Osteoarthritis

Drugs mentioned

• ZILRETTA (Triamcinolone acetonide extended-release injectable suspension)

Snippet

Sponsor: Pacira Pharmaceuticals, Inc | Conditions: Glenohumeral Osteoarthritis | Phase 3 | Status: RECRUITING